I’m 63 and have been diagnosed with atrial fibrillation. I wonder what you know about medical care and self-care for the ...

Amgen has a lot riding on an experimental obesity drug that it hopes will rival those of Eli Lilly and Novo Nordisk. But one ...

Eli Lilly & Co plans to invest £279 million ($364 million) in a new initiative to support UK biotechs along with a study of ...

Giving older Americans access to weight-loss medicines through the US Medicare program would cost $35 billion over nine years ...

A review of the recent evidence suggests that GLP-1 drugs, such as semaglutide, could protect brain health and cognitive ...

Ilant estimates that behavioral therapy can help many people lose up to 5% of their weight, anti-obesity medications can help ...

A groundbreaking weight loss invention could soon make it possible to drop those extra pounds without a single change in your diet.

Researchers have unveiled a novel approach to tackle obesity by targeting fat absorption in the small intestine. The ...

PBMs are putting weight loss drugs, including Wegovy and Zepbound, on their national formularies, but coverage by plans is ...

Authorizing Medicare to cover weight loss drugs would increase federal spending by about $35 billion from 2026 to 2034 ...

Medicare is prohibited by law from covering GLP-1 drugs for weight loss. But many beneficiaries can access the drugs anyway.

When you think of brain stimulating medtech, startups building wearables as therapeutics probably aren't the first thing that ...